Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-055195

Chairman and CEO bought 3,000 shares at an average $1.67 ($4,995)

From the SEC's structured data for this filing

Trades in this filing

Niihara Yutaka · Chairman and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-03 Purchase : show line 1 in the form +1,500 $1.58 $2,370 10,869,065 D
2021-09-08 Purchase : show line 2 in the form +1,500 $1.75 $2,625 10,870,565 D
Open-market purchases · 3,000 sh · avg $1.67 · $4,995
Loading xslF345X03/doc4.xml…